查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1751229

性病诊断市场规模、份额、趋势分析报告：按应用、产品、技术、检测地点、地区、细分市场预测，2025-2030 年

STD Diagnostics Market Size, Share & Trends Analysis Report By Application (HIV Testing, HSV Testing, Chlamydia Testing), By Product, By Technology, By Location Of Testing, By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 156 Pages | 商品交期: 2-10个工作天内

价格

性病诊断市场的成长与趋势：

根据Grand View Research, Inc.的最新报告，全球性病诊断市场规模预计到2030年将达到160.8亿美元，2025年至2030年期间的复合年增长率为7.1%。

性行为感染传染病（STD）负担日益加重，以及各国政府和非营利组织努力提高年轻一代的认识并鼓励定期筛检，是推动市场成长的主要因素。根据世界卫生组织的数据，全球每年报告约3.74亿例梅毒、淋病、披衣菌感染和滴虫病等性传染病新发病例。

新一代HIV检测套组和多重PCR产品等先进产品的开发和商业化，使医生能够及时诊断和区分各种性传染感染，并提供适当的治疗。总部位于韩国的诊断公司Seegene, Inc.提供Allplex、Anyplex和Seeplex等广泛的产品组合，可检测各种病原体。例如，Allplex STI/BV Panel Assay可在一次检测中区分出28种病原体。 2022年4月，Seegene, Inc.宣布开发Allplex HPV HR检测。

Allplex HPV HR 检测是全球首个商业化的「3 Ct」 PCR 检测。 Seegene 致力于将这项技术应用于其整个产品链，包括性传染感染 (STI)、尿道感染(UTI) 和呼吸道病毒 (RV) 检测。这项策略性技术进步预计将为公司在性行为感染传染病 (STD) 诊断行业扩大市场份额提供进一步优势。

《爱滋病毒国家战略计画》是美国到2030年消除人类免疫力缺乏病毒流行的蓝图。该计划从2021年到2025年，是美国第三个五年期爱滋病毒国家计划，其十年目标是到2030年将人类免疫力缺乏病毒新兴感染减少一半至90%。此外，《病毒性肝炎国家战略计画》重点关注性传播的B型肝炎和C肝。 2021年1月，美国卫生与公众服务部（HHS）发布了一项国家战略，以应对美国病毒性肝炎带来的可预防和重大公共卫生威胁。政府的有利行动正在为性病诊断行业的扩张营造良好的氛围。

各公司都在采取策略性倡议，支持新产品开发和监管核准，并加强其性传染病 (STD) 诊断产品系列。例如，2020 年 8 月，DiaSorin 公司获得美国FDA 的 510(k)核准，推出用于诊断乙型肝炎病毒 (HBV) 感染的 LIAISON XL MUREX 抗 HBe 试剂。此免疫测量产品基于化学冷光原理运作。

性病诊断市场报告重点

  • 到 2024 年，耗材领域将占据市场主导地位，收益占有率达 70.01%，并且由于检测率高和多种性病诊断检测方法的商业化，预计预测期内该领域将以最快的复合年增长率增长。
  • 从技术角度来看，由于高通量PCR技术的使用日益增多，以及NAAT检测在HIV检测中的应用日益普及，分子诊断领域预计将在预测期内实现最快的复合年增长率。能够同时检测多种病原体的多重PCR检测技术的发展，预计也将有助于性病诊断产业的成长。
  • 根据应用，预计 2024 年 HIV 检测领域将在 STD 诊断产业中占据主导地位。这是由于 HIV 盛行率高、分子检测产品核可增加以及政府的有利措施等因素造成的。
  • 由于性病检测率上升、可支配收入增加以及新兴国家性病患病率高，预计亚太国家在预测期内将以最快的速度成长。

目录

第一章调查方法与范围

第二章执行摘要

第三章 性病诊断市场变数、趋势与范围

  • 市场介绍/电网展望
  • 市场规模和成长前景
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
  • 性病诊断市场分析工具
    • 波特分析
    • PESTEL分析

第四章 性病诊断市场：产品评估与趋势分析

  • 细分仪表板
  • 性病诊断市场：2024 年和 2030 年产品差异分析
  • 设备和服务
  • 耗材
  • 软体

第五章 性病诊断市场：应用估计与趋势分析

  • 细分仪表板
  • 性病诊断市场：2024 年和 2030 年应用趋势分析
  • CT/NG检查
  • 梅毒检测
    • PCR检测
    • 非PCR检测
  • 淋病检测
  • HSV侦测
    • PCR检测
    • 非PCR检测
  • HPV检测
  • HIV检测
  • 脲原体和霉浆菌检测
  • 滴虫
  • VZV检测
    • PCR检测
    • 非PCR检测

第六章 性病诊断市场：技术评估与趋势分析

  • 细分仪表板
  • 性病诊断市场：2024 年与 2030 年技术变迁分析
  • 免疫检测
  • 分子诊断
  • 其他的

第七章性行为感染传染病诊断市场：检测地点估计与趋势分析

  • 细分仪表板
  • 性病诊断市场：检测变异分析（2024 年和 2030 年）
  • 商业/私人实验室
  • 公共卫生研究所

第八章性行为感染传染病诊断市场：区域估计与趋势分析

  • 2024 年及 2030 年各地区性病诊断市场占有率
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 丹麦
    • 瑞典
    • 挪威
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 韩国
    • 泰国
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第九章 竞争态势

  • 主要市场参与企业的近期趋势和影响分析
  • 公司分类
  • 公司热图分析
  • 公司简介
    • BD
    • F. Hoffmann-La Roche Ltd
    • Hologic Inc.
    • Abbott
    • Cepheid（Danaher）
    • Qiagen
    • OraSure Technologies, Inc.
    • Bio-Rad Laboratories, Inc.
    • bioMerieux SA
    • Thermo Fisher Scientific, Inc.
    • Seegene Inc.
    • DiaSorin SpA
Product Code: 978-1-68038-686-8

STD Diagnostics Market Growth & Trends:

The global STD diagnostics market size is estimated to reach USD 16.08 billion by 2030, expanding at a CAGR of 7.1% from 2025 to 2030, according to a new report by Grand View Research, Inc. The increasing disease burden of Sexually Transmitted Disease (STD) and efforts by government & non-profit organizations to increase awareness and encourage regular screenings among the younger population are the key factors augmenting the market growth. According to WHO data, around 374 million new cases of syphilis, gonorrhea, chlamydia, and trichomoniasis are recorded every year globally.

Development and commercialization of advanced products, such as next-generation HIV testing kits and multiplex PCR products, enable physicians to timely diagnose & distinguish a range of STIs and provide appropriate treatment. Seegene, Inc., a South Korea-based diagnostic company, provides a wide portfolio of Allplex, Anyplex, and Seeplex products that detect various causative agents. For instance, Allplex STI/BV Panel Assay can distinguish 28 causative agents in a single test. In April 2022, Seegene, Inc. announced the development of Allplex HPV HR Detection.

Allplex HPV HR Detection is the world's first commercialized '3 Ct' PCR assay. Seegene is focusing to apply this technology to its entire product chain, including STI, Urinary Tract Infection (UTI), and Respiratory Virus (RV) assays. This strategic technological advancement is expected to provide an additional advantage to the company that can help increase its share in the Sexually Transmitted Disease (STD) diagnostics industry.

The HIV National Strategic Plan is a roadmap for eliminating the human immunodeficiency virus pandemic in the U.S. by 2030. The HIV Plan, which will run from 2021 to 2025, is the country's third five-year national HIV plan in a row, with a 10-year goal of halving new human immunodeficiency virus infections by 90% by 2030. Furthermore, the Viral Hepatitis National Strategic Plan focuses on hepatitis B and C, which are sexually transmitted. In January 2021, the US Department of Health and Human Services (HHS) released a nationwide strategy to address the preventable, substantial public health threats posed by viral hepatitis in the United States. The government's beneficial actions create a favorable atmosphere for the expansion of the STD diagnostics industry.

Companies are engaging in strategic initiatives that aid in the development of new products, and regulatory approvals as well as enhance their STD diagnostics product portfolio. For instance, in August 2020, DiaSorin, Inc. received 510 (k) approval from U.S. FDA for introducing LIAISON XL MUREX anti-HBe. It is used for the diagnosis of HBV infection. This immunoassay product works on the principle of chemiluminescence.

STD Diagnostics Market Report Highlights:

  • The consumables segment dominated the market in 2024 with a revenue share of 70.01% and is anticipated to grow at the fastest CAGR over the forecast period owing to high testing rates for the diagnosis of STDs and the commercialization of several assays
  • Based on technology, the molecular diagnostics segment is estimated to grow at the fastest CAGR during the forecast period owing to the increasing use of high-throughput PCR technology and the recommendation of NAAT tests for HIV testing. The development of multiplex PCR tests for the simultaneous detection of multiple pathogens is also expected to contribute to the STD diagnostics industry's growth
  • Based on application, the HIV testing segment is expected to dominate the STD diagnostics industry in 2024, due to factors such as the high incidence rate of the disease, increasing product approvals for molecular tests, and favorable government initiatives
  • Asia Pacific region is anticipated to experience the fastest growth over the forecast period due to an increase in testing rates for STDS, a rise in disposable income, and high disease prevalence of STD in developing countries

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
  • 1.3. Research Methodology
    • 1.3.1. Information Procurement
    • 1.3.2. Information or Data Analysis
    • 1.3.3. Market Formulation & Data Visualization
    • 1.3.4. Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1. List of Data Sources

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. STD Diagnostics Market Variables, Trends, & Scope

  • 3.1. Market Introduction/Lineage Outlook
  • 3.2. Market Size and Growth Prospects (USD Million)
  • 3.3. Market Dynamics
    • 3.3.1. Market Drivers Analysis
    • 3.3.2. Market Restraints Analysis
  • 3.4. STD Diagnostics Market Analysis Tools
    • 3.4.1. Porter's Analysis
      • 3.4.1.1. Bargaining power of the suppliers
      • 3.4.1.2. Bargaining power of the buyers
      • 3.4.1.3. Threats of substitution
      • 3.4.1.4. Threats from new entrants
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Economic and Social landscape
      • 3.4.2.3. Technological landscape
      • 3.4.2.4. Environmental landscape
      • 3.4.2.5. Legal landscape

Chapter 4. STD Diagnostics Market: Product Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. STD Diagnostics Market: Product Movement Analysis, 2024 & 2030 (USD Million)
  • 4.3. Instruments and Services
    • 4.3.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.4. Consumables
    • 4.4.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.5. Software
    • 4.5.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. STD Diagnostics Market: Application Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. STD Diagnostics Market: Application Movement Analysis, 2024 & 2030 (USD Million)
  • 5.3. CT/NG testing
    • 5.3.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.4. Syphilis testing
    • 5.4.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.4.2. PCR testing
      • 5.4.2.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.4.3. Non-PCR testing
      • 5.4.3.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.5. Gonorrhea testing
    • 5.5.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.6. HSV testing
    • 5.6.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.6.2. PCR testing
      • 5.6.2.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.6.3. Non-PCR testing
      • 5.6.3.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.7. HPV testing
    • 5.7.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.8. HIV testing
    • 5.8.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.9. Ureaplasma & Mycoplasma testing
    • 5.9.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.10. Trichomonas
    • 5.10.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.11. VZV testing
    • 5.11.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.11.2. PCR testing
      • 5.11.2.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.11.3. Non-PCR testing
      • 5.11.3.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. STD Diagnostics Market: Technology Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. STD Diagnostics Market: Technology Movement Analysis, 2024 & 2030 (USD Million)
  • 6.3. Immunoassay
    • 6.3.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.4. Molecular Diagnostics
    • 6.4.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5. Other
    • 6.5.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. STD Diagnostics Market: Location of Testing Estimates & Trend Analysis

  • 7.1. Segment Dashboard
  • 7.2. STD Diagnostics Market: Location of Testing Movement Analysis, 2024 & 2030 (USD Million)
  • 7.3. Commercial/Private labs
    • 7.3.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.4. Public Health Labs
    • 7.4.1. Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. STD Diagnostics Market: Regional Estimates & Trend Analysis

  • 8.1. STD Diagnostics Market Share, By Region, 2024 & 2030, USD Million
  • 8.2. North America
    • 8.2.1. North America STD Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.2.2. U.S.
      • 8.2.2.1. U.S. STD Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.2.3. Canada
      • 8.2.3.1. Canada STD Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.2.4. Mexico
      • 8.2.4.1. Mexico STD Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.3. Europe
    • 8.3.1. Europe STD Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.3.2. UK
      • 8.3.2.1. UK STD Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.3.3. Germany
      • 8.3.3.1. Germany STD Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.3.4. France
      • 8.3.4.1. France STD Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.3.5. Italy
      • 8.3.5.1. Italy STD Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.3.6. Spain
      • 8.3.6.1. Spain STD Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.3.7. Denmark
      • 8.3.7.1. Denmark STD Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.3.8. Sweden
      • 8.3.8.1. Sweden STD Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.3.9. Norway
      • 8.3.9.1. Norway STD Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.4. Asia Pacific
    • 8.4.1. Asia Pacific STD Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.4.2. Japan
      • 8.4.2.1. Japan STD Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.4.3. China
      • 8.4.3.1. China STD Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.4.4. India
      • 8.4.4.1. India STD Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.4.5. Australia
      • 8.4.5.1. Australia STD Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.4.6. South Korea
      • 8.4.6.1. South Korea STD Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.4.7. Thailand
      • 8.4.7.1. Thailand STD Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.5. Latin America
    • 8.5.1. Latin America STD Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.5.2. Brazil
      • 8.5.2.1. Brazil STD Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.5.3. Argentina
      • 8.5.3.1. Argentina STD Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.6. Middle East and Africa
    • 8.6.1. Middle East and Africa STD Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.6.2. South Africa
      • 8.6.2.1. South Africa STD Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.6.3. Saudi Arabia
      • 8.6.3.1. South Africa STD Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.6.4. UAE
      • 8.6.4.1. UAE STD Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.6.5. Kuwait
      • 8.6.5.1. Kuwait STD Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 9. Competitive Landscape

  • 9.1. Recent Developments & Impact Analysis by Key Market Participants
  • 9.2. Company Categorization
  • 9.3. Company Heat Map Analysis
  • 9.4. Company Profiles
    • 9.4.1. BD
      • 9.4.1.1. Participant's Overview
      • 9.4.1.2. Financial Performance
      • 9.4.1.3. Product Benchmarking
      • 9.4.1.4. Recent Developments/ Strategic Initiatives
    • 9.4.2. F. Hoffmann-La Roche Ltd
      • 9.4.2.1. Participant's Overview
      • 9.4.2.2. Financial Performance
      • 9.4.2.3. Product Benchmarking
      • 9.4.2.4. Recent Developments/ Strategic Initiatives
    • 9.4.3. Hologic Inc.
      • 9.4.3.1. Participant's Overview
      • 9.4.3.2. Financial Performance
      • 9.4.3.3. Product Benchmarking
      • 9.4.3.4. Recent Developments/ Strategic Initiatives
    • 9.4.4. Abbott
      • 9.4.4.1. Participant's Overview
      • 9.4.4.2. Financial Performance
      • 9.4.4.3. Product Benchmarking
      • 9.4.4.4. Recent Developments/ Strategic Initiatives
    • 9.4.5. Cepheid (Danaher)
      • 9.4.5.1. Participant's Overview
      • 9.4.5.2. Financial Performance
      • 9.4.5.3. Product Benchmarking
      • 9.4.5.4. Recent Developments/ Strategic Initiatives
    • 9.4.6. Qiagen
      • 9.4.6.1. Participant's Overview
      • 9.4.6.2. Financial Performance
      • 9.4.6.3. Product Benchmarking
      • 9.4.6.4. Recent Developments/ Strategic Initiatives
    • 9.4.7. OraSure Technologies, Inc.
      • 9.4.7.1. Participant's Overview
      • 9.4.7.2. Financial Performance
      • 9.4.7.3. Product Benchmarking
      • 9.4.7.4. Recent Developments/ Strategic Initiatives
    • 9.4.8. Bio-Rad Laboratories, Inc.
      • 9.4.8.1. Participant's Overview
      • 9.4.8.2. Financial Performance
      • 9.4.8.3. Product Benchmarking
      • 9.4.8.4. Recent Developments/ Strategic Initiatives
    • 9.4.9. bioMerieux SA
      • 9.4.9.1. Participant's Overview
      • 9.4.9.2. Financial Performance
      • 9.4.9.3. Product Benchmarking
      • 9.4.9.4. Recent Developments/ Strategic Initiatives
    • 9.4.10. Thermo Fisher Scientific, Inc.
      • 9.4.10.1. Participant's Overview
      • 9.4.10.2. Financial Performance
      • 9.4.10.3. Product Benchmarking
      • 9.4.10.4. Recent Developments/ Strategic Initiatives
    • 9.4.11. Seegene Inc.
      • 9.4.11.1. Participant's Overview
      • 9.4.11.2. Financial Performance
      • 9.4.11.3. Product Benchmarking
      • 9.4.11.4. Recent Developments/ Strategic Initiatives
    • 9.4.12. DiaSorin S.p.A
      • 9.4.12.1. Participant's Overview
      • 9.4.12.2. Financial Performance
      • 9.4.12.3. Product Benchmarking
      • 9.4.12.4. Recent Developments/ Strategic Initiatives

List of Tables

  • Table 1 List of abbreviation
  • Table 2 Global STD diagnostics market, by region, 2018 - 2030 (USD Million)
  • Table 3 Global STD diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 4 Global STD diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 5 Global STD diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 6 Global STD diagnostics market, by location of testing, 2018 - 2030 (USD Million)
  • Table 7 North America STD diagnostics market, by country, 2018 - 2030 (USD Million)
  • Table 8 North America STD diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 9 North America STD diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 10 North America STD diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 11 North America STD diagnostics market, by location of testing, 2018 - 2030 (USD Million)
  • Table 12 U.S. STD diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 13 U.S. STD diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 14 U.S. STD diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 15 U.S. STD diagnostics market, by location of testing, 2018 - 2030 (USD Million)
  • Table 16 Canada STD diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 17 Canada STD diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 18 Canada STD diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 19 Canada STD diagnostics market, by location of testing, 2018 - 2030 (USD Million)
  • Table 20 Mexico STD diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 21 Mexico STD diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 22 Mexico STD diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 23 Mexico STD diagnostics market, by location of testing, 2018 - 2030 (USD Million)
  • Table 24 Europe STD diagnostics market, by country, 2018 - 2030 (USD Million)
  • Table 25 Europe STD diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 26 Europe STD diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 27 Europe STD diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 28 Europe STD diagnostics market, by location of testing, 2018 - 2030 (USD Million)
  • Table 29 UK STD diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 30 UK STD diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 31 UK STD diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 32 UK STD diagnostics market, by location of testing, 2018 - 2030 (USD Million)
  • Table 33 Germany STD diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 34 Germany STD diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 35 Germany STD diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 36 Germany STD diagnostics market, by location of testing, 2018 - 2030 (USD Million)
  • Table 37 France STD diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 38 France STD diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 39 France STD diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 40 France STD diagnostics market, by location of testing, 2018 - 2030 (USD Million)
  • Table 41 Italy STD diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 42 Italy STD diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 43 Italy STD diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 44 Italy STD diagnostics market, by location of testing, 2018 - 2030 (USD Million)
  • Table 45 Spain STD diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 46 Spain STD diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 47 Spain STD diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 48 Spain STD diagnostics market, by location of testing, 2018 - 2030 (USD Million)
  • Table 49 Denmark STD diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 50 Denmark STD diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 51 Denmark STD diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 52 Denmark STD diagnostics market, by location of testing, 2018 - 2030 (USD Million)
  • Table 53 Sweden STD diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 54 Sweden STD diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 55 Sweden STD diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 56 Sweden STD diagnostics market, by location of testing, 2018 - 2030 (USD Million)
  • Table 57 Norway STD diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 58 Norway STD diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 59 Norway STD diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 60 Norway STD diagnostics market, by location of testing, 2018 - 2030 (USD Million)
  • Table 61 Asia Pacific STD diagnostics market, by country, 2018 - 2030 (USD Million)
  • Table 62 Asia Pacific STD diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 63 Asia Pacific STD diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 64 Asia Pacific STD diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 65 Asia Pacific STD diagnostics market, by location of testing, 2018 - 2030 (USD Million)
  • Table 66 Japan STD diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 67 Japan STD diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 68 Japan STD diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 69 Japan STD diagnostics market, by location of testing, 2018 - 2030 (USD Million)
  • Table 70 China STD diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 71 China STD diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 72 China STD diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 73 China STD diagnostics market, by location of testing, 2018 - 2030 (USD Million)
  • Table 74 India STD diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 75 India STD diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 76 India STD diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 77 India STD diagnostics market, by location of testing, 2018 - 2030 (USD Million)
  • Table 78 Australia STD diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 79 Australia STD diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 80 Australia STD diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 81 Australia STD diagnostics market, by location of testing, 2018 - 2030 (USD Million)
  • Table 82 South Korea STD diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 83 South Korea STD diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 84 South Korea STD diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 85 South Korea STD diagnostics market, by location of testing, 2018 - 2030 (USD Million)
  • Table 86 Thailand STD diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 87 Thailand STD diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 88 Thailand STD diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 89 Thailand STD diagnostics market, by location of testing, 2018 - 2030 (USD Million)
  • Table 90 Latin America STD diagnostics market, by country, 2018 - 2030 (USD Million)
  • Table 91 Latin America STD diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 92 Latin America STD diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 93 Latin America STD diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 94 Latin America STD diagnostics market, by location of testing, 2018 - 2030 (USD Million)
  • Table 95 Brazil STD diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 96 Brazil STD diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 97 Brazil STD diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 98 Brazil STD diagnostics market, by location of testing, 2018 - 2030 (USD Million)
  • Table 99 Argentina STD diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 100 Argentina STD diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 101 Argentina STD diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 102 Argentina STD diagnostics market, by location of testing, 2018 - 2030 (USD Million)
  • Table 103 MEA STD diagnostics market, by country, 2018 - 2030 (USD Million)
  • Table 104 MEA STD diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 105 MEA STD diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 106 MEA STD diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 107 MEA STD diagnostics market, by location of testing, 2018 - 2030 (USD Million)
  • Table 108 South Africa STD diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 109 South Africa STD diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 110 South Africa STD diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 111 South Africa STD diagnostics market, by location of testing, 2018 - 2030 (USD Million)
  • Table 112 Saudi Arabia STD diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 113 Saudi Arabia STD diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 114 Saudi Arabia STD diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 115 Saudi Arabia STD diagnostics market, by location of testing, 2018 - 2030 (USD Million)
  • Table 116 UAE STD diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 117 UAE STD diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 118 UAE STD diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 119 UAE STD diagnostics market, by location of testing, 2018 - 2030 (USD Million)
  • Table 120 Kuwait STD diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 121 Kuwait STD diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 122 Kuwait STD diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 123 Kuwait STD diagnostics market, by location of testing, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 STD Diagnostics Market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Information procurement
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 QFD modeling for market share assessment
  • Fig. 8 Market formulation & validation
  • Fig. 9 Market outlook (2023)
  • Fig. 10 Penetration and growth prospect mapping
  • Fig. 11 User perspective analysis
  • Fig. 12 STD Diagnostics Market driver impact
  • Fig. 13 Prevalence of STIs by WHO regions (in 2023)
  • Fig. 14 STD Diagnostics Market restraint impact
  • Fig. 15 SWOT Analysis, By Factor (Political & Legal, Economic, and Technological)
  • Fig. 16 Porter's Five Forces Analysis
  • Fig. 17 STD diagnostics product outlook: Key takeaways
  • Fig. 18 STD Diagnostics Market: Product movement analysis
  • Fig. 19 Instruments and Services market, 2018 - 2030 (USD Million)
  • Fig. 20 Consumables market, 2018 - 2030 (USD Million)
  • Fig. 21 Software market, 2018 - 2030 (USD Million)
  • Fig. 22 STD diagnostics application outlook: Key takeaways
  • Fig. 23 STD Diagnostics Market: Application movement analysis
  • Fig. 24 CT/NG testing market, 2018 - 2030 (USD Million)
  • Fig. 25 Prevalence (%) of syphilis by WHO regions
  • Fig. 26 Syphilis testing market, 2018 - 2030 (USD Million)
  • Fig. 27 Syphilis PCR testing market, 2018 - 2030 (USD Million)
  • Fig. 28 Syphilis non-PCR testing market, 2018 - 2030 (USD Million)
  • Fig. 29 HSV testing market, 2018 - 2030 (USD Million)
  • Fig. 30 Herpes Simplex Virus PCR testing market, 2018 - 2030 (USD Million)
  • Fig. 31 Herpes Simplex Virus non-PCR testing market, 2018 - 2030 (USD Million)
  • Fig. 32 HPV testing market, 2018 - 2030 (USD Million)
  • Fig. 33 Prevalence (%) of HIV by WHO regions
  • Fig. 34 HIV testing market, 2018 - 2030 (USD Million)
  • Fig. 35 Ureaplasma & mycoplasma testing market, 2018 - 2030 (USD Million)
  • Fig. 36 Trichomonas testing market, 2018 - 2030 (USD Million)
  • Fig. 37 VZV testing market, 2018 - 2030 (USD Million)
  • Fig. 38 VZV PCR testing market, 2018 - 2030 (USD Million)
  • Fig. 39 VZV non-PCR testing market, 2018 - 2030 (USD Million)
  • Fig. 40 Other testing market, 2018 - 2030 (USD Million)
  • Fig. 41 STD diagnostics technology outlook: Key takeaways
  • Fig. 42 STD Diagnostics Market: Technology movement analysis
  • Fig. 43 Molecular Diagnostics market, 2018 - 2030 (USD Million)
  • Fig. 44 Immunoassay market, 2018 - 2030 (USD Million)
  • Fig. 45 Others market, 2018 - 2030 (USD Million)
  • Fig. 46 STD diagnostics location of testing outlook: Key takeaways
  • Fig. 47 STD Diagnostics Market: Location of testing movement analysis
  • Fig. 48 Laboratory testing market, 2018 - 2030 (USD Million)
  • Fig. 49 Commercial/private labs market, 2018 - 2030 (USD Million)
  • Fig. 50 Public health labs market, 2018 - 2030 (USD Million)
  • Fig. 51 Point of care testing market, 2018 - 2030 (USD Million)
  • Fig. 52 Regional outlook, 2023 & 2030
  • Fig. 53 Regional marketplace: Key takeaways
  • Fig. 54 North America SWOT
  • Fig. 55 North America STD Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 56 U.S. Country Dynamics
  • Fig. 57 U.S. Target Disease Prevalence
  • Fig. 58 U.S. STD Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 59 Canada Country Dynamics
  • Fig. 60 Canada Target Disease Prevalence
  • Fig. 61 Canada STD Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 61 Mexico Target Disease Prevalence
  • Fig. 62 Mexico STD Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 62 Europe SWOT
  • Fig. 63 Europe STD Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 64 UK Country Dynamics
  • Fig. 65 UK Target Disease Prevalence
  • Fig. 66 UK STD Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 67 Germany Country Dynamics
  • Fig. 68 Germany Target Disease Prevalence
  • Fig. 69 Germany STD Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 70 France Country Dynamics
  • Fig. 71 France Target Disease Prevalence
  • Fig. 72 France STD Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 73 Spain Country Dynamics
  • Fig. 74 Spain Target Disease Prevalence
  • Fig. 75 Spain STD Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 76 Italy Country Dynamics
  • Fig. 77 Italy Target Disease Prevalence
  • Fig. 78 Italy STD Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 79 Denmark Country Dynamics
  • Fig. 80 Denmark Target Disease Prevalence
  • Fig. 81 Denmark STD Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 82 Sweden Country Dynamics
  • Fig. 83 Sweden Target Disease Prevalence
  • Fig. 84 Sweden STD Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 85 Denmark Country Dynamics
  • Fig. 86 Denmark Target Disease Prevalence
  • Fig. 87 Denmark STD Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 88 Asia Pacific SWOT
  • Fig. 89 Asia Pacific STD Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 90 Japan Country Dynamics
  • Fig. 91 Japan Target Disease Prevalence
  • Fig. 92 Japan STD Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 93 China Country Dynamics
  • Fig. 94 China Target Disease Prevalence
  • Fig. 95 China STD Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 96 India Country Dynamics
  • Fig. 97 India Target Disease Prevalence
  • Fig. 98 India STD Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 99 Australia Country Dynamics
  • Fig. 100 Australia Target Disease Prevalence
  • Fig. 101 Australia STD Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 102 South Korea Country Dynamics
  • Fig. 103 South Korea Target Disease Prevalence
  • Fig. 104 South Korea STD Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 105 Thailand Country Dynamics
  • Fig. 106 Thailand Target Disease Prevalence
  • Fig. 107 Thailand STD Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 108 Latin America SWOT
  • Fig. 109 Latin America STD Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 110 Brazil Country Dynamics
  • Fig. 111 Brazil Target Disease Prevalence
  • Fig. 112 Brazil STD Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 113 Mexico Country Dynamics
  • Fig. 116 Argentina Country Dynamics
  • Fig. 117 Argentina Target Disease Prevalence
  • Fig. 118 Argentina STD Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 119 Middle East & Africa SWOT
  • Fig. 120 Middle East & Africa STD Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 121 South Africa Country Dynamics
  • Fig. 122 South Africa Target Disease Prevalence
  • Fig. 123 South Africa STD Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 124 Saudi Arabia Country Dynamics
  • Fig. 125 Saudi Arabia Target Disease Prevalence
  • Fig. 126 Saudi Arabia STD Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 127 UAE Country Dynamics
  • Fig. 128 UAE Target Disease Prevalence
  • Fig. 129 UAE STD Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 130 Kuwait Country Dynamics
  • Fig. 131 Kuwait Target Disease Prevalence
  • Fig. 132 Kuwait STD Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 133 Heat map analysis
  • Fig. 134 Company market share analysis (2024)
  • Fig. 135 Company market position analysis (2024)
  • Fig. 136 Company market position analysis (2024)
  • Fig. 137 Market differentiators
  • Fig. 138 Regional Network Map